The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded study.

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

As more women seek hormone replacement therapy, or HRT, the shortage of estrogen patches increases, forcing them to look for ...

A decades-old warning rooted in flawed research kept millions of women from life-changing treatment, officials say.

For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...

With the risk for bone fracture high in patients with amenorrhea caused by anorexia or excessive exercise, studies show transdermal HRT provides more favorable bone benefits than oral HRT.

A surge in demand for hormone replacement therapy has caused a shortage in estrogen patches. Many women who are unable to get ...

Women who use vaginal estrogen to manage early menopause after treatment for endometrial cancer may not have an increased risk for recurrence.

Women who can’t get the menopause hormone therapy they need after years of shortages are cutting patches in half, leaving ...

Real-world data from more than 137,000 women shows early HRT significantly improves long term bone health ...

Opinion editor’s note: Strib Voices publishes a mix of material from eight contributing columnists , along with other commentary online and in print each day. To contribute, click here . ••• Hot ...

There's one 'very important' way to support your cognitive health.